N2-Phenylacetyl guanosine,
132628-16-1,
N2-Phenylacetylguanosine,
N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-phenylacetamide,
MFCD06657651,
C18H19N5O6,
N-(Phenylacetyl)guanosine,
AK-57890,
SCHEMBL9076102,
CTK0H3539,
DTXSID20440202,
ACT06791,
5995AA,
ANW-63993,
DT1150,
ZINC38897397,
AKOS015900457,
CM14343,
AJ-97125,
AN-32155,
AS-10376,
AX8018045,
FT-0654941,
N-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-3H-purin-2-yl]-2-phenylacetamide,
N-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-oxo-3H-purin-2-yl]-2-phenyl-acetamide,
N-{9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-6,9-dihydro-3H-purin-2-yl}-2-phenylacetamide,
ACN-043104,
CID10453663,
CID 10453663,